Search - tctmd.com

Displaying 421 - 440 of 719

Sort: Relevancy | Date

News Industry News

BioTrace Medical’s Tempo Lead Obtains CE Mark for Safe and Secure Temporary Intracardiac Pacing

May 08, 2019

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Industry News

SentreHEART Receives CE Mark for LARIAT-RS™ 50mm and Expanded Indication for Left Atrial Appendage Exclusion

May 03, 2019

News Industry News

First-of-its-Kind Large Access Dilator Launches in U.S., Following Cleveland Clinic Case

May 02, 2019

News Daily News

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Todd Neale

May 01, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2019

Shelley Wood

May 01, 2019

News Industry News

Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead

May 01, 2019

News Daily News

Women Have Higher Risk of TAVR-Related Pericardial Complications

Todd Neale

April 26, 2019

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

News Industry News

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

April 23, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Industry News

Cook Medical Provides Patient-Level Paclitaxel Data From Randomised Control Trial

April 19, 2019

News Daily News

Cardioband Reduces Severe Tricuspid Regurgitation at 6 Months, With Good Safety: TRI-REPAIR

Yael L. Maxwell

April 17, 2019

News Industry News

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

April 17, 2019

News Conference News ACC 2019

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

Shelley Wood

April 05, 2019

News Daily News

Volume Still an Important Surrogate for TAVR Quality, New Data Suggest

Todd Neale

April 03, 2019

News Daily News

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

Yael L. Maxwell

April 01, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Conference News ACC 2019

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Yael L. Maxwell

March 17, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

Advertisement

BioTrace Medical’s Tempo Lead Obtains CE Mark for Safe and Secure Temporary Intracardiac Pacing

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

SentreHEART Receives CE Mark for LARIAT-RS™ 50mm and Expanded Indication for Left Atrial Appendage Exclusion

First-of-its-Kind Large Access Dilator Launches in U.S., Following Cleveland Clinic Case

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

TCTMD’s Top 10 Most Popular Stories for April 2019

Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead

Women Have Higher Risk of TAVR-Related Pericardial Complications

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

Cook Medical Provides Patient-Level Paclitaxel Data From Randomised Control Trial

Cardioband Reduces Severe Tricuspid Regurgitation at 6 Months, With Good Safety: TRI-REPAIR

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

Volume Still an Important Surrogate for TAVR Quality, New Data Suggest

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content